Inside Hospital's Ebola Battle | The New York Times
Ebola Outbreak 2014: At the government hospital in Kenema, Sierra Leone, health care workers struggle to contain the Ebola epidemic, which has killed almost 1,000 people across West Africa.

Produced by: Ben C. Solomon

Read the story here: http://nyti.ms/1owPkBz

Subscribe to the Times Video newsletter for free and get a handpicked selection of the best videos from The New York Times every week: http://bit.ly/timesvideonewsletter

Subscribe on YouTube: http://bit.ly/U8Ys7n

Watch more videos at: http://nytimes.com/video

---------------------------------------------------------------

Want more from The New York Times?

Twitter: https://twitter.com/nytvideo

Facebook: https://www.facebook.com/nytimes

Google+: https://plus.google.com/+nytimes/

Whether it's reporting on conflicts abroad and political divisions at home, or covering the latest style trends and scientific developments, New York Times video journalists provide a revealing and unforgettable view of the world. It's all the news that's fit to watch. On YouTube.

Inside Hospital's Ebola Battle | The New York Times
http://www.youtube.com/user/TheNewYorkTimes

Access Non-GMO, antigen-free, generic antiviral medication formulas used in Moderna's Spikevax.

VirusTC is a retail provider of concentrated generic antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, Mayo Clinic, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.